相似文献
1
KAI1 gene expression in colonic carcinoma and its clinical significances.
World J Gastroenterol. 2004 Aug 1;10(15):2245-9. doi: 10.3748/wjg.v10.i15.2245.
2
Loss of KAI1 expression in the progression of colorectal cancer.
Cancer Res. 1999 Nov 15;59(22):5724-31.
3
Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
Surgery. 1999 Nov;126(5):869-80.
4
KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Hepatology. 1998 Dec;28(6):1481-8. doi: 10.1002/hep.510280606.
5
KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
Cancer Res. 2004 Jun 15;64(12):4235-43. doi: 10.1158/0008-5472.CAN-04-0275.
6
KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
Am J Pathol. 2001 Nov;159(5):1629-34. doi: 10.1016/s0002-9440(10)63009-x.
7
[Effect of tumor suppressor gene KAI1 on the biological behaviors of human colorectal carcinoma].
Di Yi Jun Yi Da Xue Xue Bao. 2003 Jun;23(6):587-90, 594.
8
Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
Anticancer Res. 2002 Nov-Dec;22(6A):3337-42.
9
Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Oncogene. 1998 Mar;16(11):1443-53. doi: 10.1038/sj.onc.1201648.
10
KAI1 protein is down-regulated during the progression of human breast cancer.
Clin Cancer Res. 2000 Sep;6(9):3424-9.
引用本文的文献
1
Tetraspanins in digestive‑system cancers: Expression, function and therapeutic potential (Review).
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13324. Epub 2024 Sep 6.
2
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy.
Biomolecules. 2020 Mar 3;10(3):388. doi: 10.3390/biom10030388.
3
Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma.
Int J Clin Exp Pathol. 2018 Jul 1;11(7):3638-3646. eCollection 2018.
4
Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.
Oncotarget. 2018 Jan 5;9(5):6369-6390. doi: 10.18632/oncotarget.23968. eCollection 2018 Jan 19.
5
Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance.
Oncol Lett. 2017 Nov;14(5):5811-5818. doi: 10.3892/ol.2017.6981. Epub 2017 Sep 18.
6
The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
World J Surg Oncol. 2016 Oct 28;14(1):276. doi: 10.1186/s12957-016-1033-z.
7
Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
World J Surg Oncol. 2014 Apr 24;12:118. doi: 10.1186/1477-7819-12-118.
8
Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Virchows Arch. 2008 Apr;452(4):369-75. doi: 10.1007/s00428-008-0590-0. Epub 2008 Feb 28.
本文引用的文献
1
Motility of colon cancer cells: modulation by CD44 isoform expression.
Exp Mol Pathol. 2003 Oct;75(2):124-30. doi: 10.1016/s0014-4800(03)00053-4.
2
Expression of KAI1/CD82 in human colorectal tumor.
Di Yi Jun Yi Da Xue Xue Bao. 2003 Jul;23(7):714-5, 719.
3
Effects of KAI1/CD82 on biological behavior of human colorectal carcinoma cell line.
World J Gastroenterol. 2003 Jun;9(6):1231-6. doi: 10.3748/wjg.v9.i6.1231.
4
Prognostic implication of nm23-H1 expression in colorectal carcinomas.
Pathology. 2002 Oct;34(5):427-32. doi: 10.1080/0031302021000009342.
5
NM23 expression as prognostic factor in colorectal carcinoma.
G Chir. 2002 Mar;23(3):61-3.
6
Genetic basis of human breast cancer metastasis.
J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):441-51. doi: 10.1023/a:1014739131690.
7
High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Clin Cancer Res. 2002 Mar;8(3):828-35.
8
KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Anticancer Res. 2001 Sep-Oct;21(5):3581-7.
9
Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Int J Cancer. 2002 Feb 1;97(4):518-25. doi: 10.1002/ijc.1625.
10
KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell-surface receptor proteins.
Mol Carcinog. 2001 Nov;32(3):139-53. doi: 10.1002/mc.1073.
Zotero 插件